Annual Working Capital
$4.65 M
-$1.93 M-29.33%
December 1, 2024
Summary
- As of March 12, 2025, REVB annual working capital is $4.65 million, with the most recent change of -$1.93 million (-29.33%) on December 1, 2024.
- During the last 3 years, REVB annual working capital has risen by +$4.88 million (+2126.13%).
- REVB annual working capital is now -29.33% below its all-time high of $6.58 million, reached on December 1, 2023.
Performance
REVB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$4.65 M
+$2.06 M+79.45%
December 1, 2024
Summary
- As of March 12, 2025, REVB quarterly working capital is $4.65 million, with the most recent change of +$2.06 million (+79.45%) on December 1, 2024.
- Over the past year, REVB quarterly working capital has dropped by -$4.74 million (-50.48%).
- REVB quarterly working capital is now -58.97% below its all-time high of $11.34 million, reached on June 30, 2023.
Performance
REVB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
REVB Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.3% | -50.5% |
| 3 y3 years | +2126.1% | -50.5% |
| 5 y5 years | - | -50.5% |
REVB Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.3% | +2126.1% | -59.0% | +339.1% |
| 5 y | 5-year | -29.3% | +2126.1% | -59.0% | +339.1% |
| alltime | all time | -29.3% | +2126.1% | -59.0% | +339.1% |
Revelation Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $4.65 M(-29.3%) | $4.65 M(+79.4%) |
| Sep 2024 | - | $2.59 M(+142.4%) |
| Jun 2024 | - | $1.07 M(-88.6%) |
| Mar 2024 | - | $9.40 M(+42.7%) |
| Dec 2023 | $6.58 M | $6.58 M(-24.7%) |
| Sep 2023 | - | $8.75 M(-22.8%) |
| Jun 2023 | - | $11.34 M(+14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $9.93 M(+932.3%) |
| Dec 2022 | $962.30 K(-519.1%) | $962.30 K(-54.8%) |
| Sep 2022 | - | $2.13 M(-209.5%) |
| Jun 2022 | - | -$1.95 M(+837.7%) |
| Mar 2022 | - | -$207.50 K(-9.6%) |
| Dec 2021 | -$229.60 K(-106.7%) | -$229.60 K(-106.6%) |
| Sep 2021 | - | $3.49 M |
| Dec 2020 | $3.41 M | - |
FAQ
- What is Revelation Biosciences annual working capital?
- What is the all time high annual working capital for Revelation Biosciences?
- What is Revelation Biosciences annual working capital year-on-year change?
- What is Revelation Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Revelation Biosciences?
- What is Revelation Biosciences quarterly working capital year-on-year change?
What is Revelation Biosciences annual working capital?
The current annual working capital of REVB is $4.65 M
What is the all time high annual working capital for Revelation Biosciences?
Revelation Biosciences all-time high annual working capital is $6.58 M
What is Revelation Biosciences annual working capital year-on-year change?
Over the past year, REVB annual working capital has changed by -$1.93 M (-29.33%)
What is Revelation Biosciences quarterly working capital?
The current quarterly working capital of REVB is $4.65 M
What is the all time high quarterly working capital for Revelation Biosciences?
Revelation Biosciences all-time high quarterly working capital is $11.34 M
What is Revelation Biosciences quarterly working capital year-on-year change?
Over the past year, REVB quarterly working capital has changed by -$4.74 M (-50.48%)